1907
XHKG
Market cap827mUSD
Nov 20, Last price
1.53HKD
1D
4.08%
1Q
-23.12%
IPO
-45.36%
Name
China Risun Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Risun Group Limited, founded in 1995 and headquartered in Beijing, People's Republic of China, is a diversified enterprise focused on the manufacturing, sale, and distribution of coke, coking chemicals, and refined chemicals throughout the PRC and via export. The company structures its operations across four primary divisions: Coke and Coking Chemicals Manufacturing, Refined Chemicals Manufacturing, Operation Management, and Trading. Its extensive portfolio of chemical products features items like crude benzene, industrial naphthalene phthalic anhydride, coke oven gas methanol, coal-tar pitch, and caprolactam. In addition to its production activities, China Risun provides operation management services to external coke and chemical firms, alongside offering training programs for safety management and operational proficiency. The group also actively trades in coke, coking chemicals, and refined chemical products, and is involved in real estate development initiatives. Its clientele spans critical sectors including iron and steel, non-ferrous metals, coking, and general chemical industries. The company was previously named China Risun Coal Chemicals Group Limited, changing to its current designation in July 2018.
Key people
Qinliang Han
Vice President, Executive Director · since 2011
Yunshan Jia
Vice President · since 2004
Xixian Yuan
Vice President · since 2017
Qinghua Li
Executive President, Executive Director · since 2024
Xiaomei Lu
Executive Director · since 2024
Nianping Wang
Vice President, Executive Director · since 2018
Xuegang Yang
Executive Chairman of the Board, Chief Executive Officer
Lu Yang
Executive Director · since 2018
Pui Lam Ho
Company Secretary
Non-Executive Independent Director · since 2024
Yinping Wang
Independent Non-Executive Director · since 2018
Kwok Kuen Yu
Independent Non-Executive Director · since 2018
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||